OSI-420,
OSI-420,
183320-51-6,
Desmethyl Erlotinib,
CP-473420,
2-((4-((3-ethynylphenyl)amino)-7-(2-methoxyethoxy)quinazolin-6-yl)oxy)ethan-1-ol hydrochloride,
2-((4-((3-ethynylphenyl)amino)-7-(2-methoxyethoxy)quinazolin-6-yl)oxy)ethan-1-ol,
OSI420 HCl,
MLS006011273,
OSI-420 (cGMP),
SCHEMBL1507689,
DTXSID50596524,
OSI-420 (Desmethyl Erlotinib),
BCP28007,
s2205,
CS-0467,
KS-00001D52,
HY-13256,
SC-94555,
SMR004703023,
SW219293-1,
X7503,
W-5937,
183320-51-6, Desmethyl Erlotinib,CP-473420,
2-({4-[(3-ethynylphenyl)amino]-7-(2-methoxyethoxy)quinazolin-6-yl}oxy)ethanol hydrochloride,
2-{[4-(3-Ethynylanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]oxy}ethan-1-ol--hydrogen chloride (1/1),
Ethanol, 2-[[4-[(3-ethynylphenyl)amino]-7-(2-methoxyethoxy)-6-quinazolinyl]oxy]-, hydrochloride (1:1),
C21H22ClN3O4,
OSI420,
OSI 420,
B1495,
A10678,
183321-86-0,